Teriparatide Injection, Solution
Product Images NDC 60505-6188

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 60505-6188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caption-1 (Caption 1)

This illustration shows the proper handling of a small vial with a red stripe, being held by two hands. The diagram appears instructional, demonstrating how to grip the vial, likely related to Teriparatide injection preparation or administration.*

FDA Label Image

Carton-label (Carton Label)

Packaging label for Teriparatide Injection, USP 250 mcg/mL subcutaneous injection by Apotex Corp. The label indicates a dose of 20 mcg per administration, with a total of 600 mcg per 2.4 mL in each single-patient-use prefilled pen delivering 28 doses. Instructions note refrigeration at 2°C to 8°C, no needle included, and single-patient use only. The label includes manufacturer details, barcode, and storage warnings.*

FDA Label Image

Figure-1 (Figure 1)

A line graph showing the percent of patients with nonvertebral osteoporotic fractures over 20 months since randomization. The graph compares two groups: Teriparatide (dashed line) and Placebo (solid line), with the percent increasing over time for both groups, and the Teriparatide group consistently having a lower percent of fractures than the Placebo group.*

FDA Label Image

Figure-10 (Figure 10)

Illustration showing the proper injection technique for subcutaneous administration of Teriparatide injection. The image depicts a hand holding a syringe angled towards the abdomen, indicating the injection site and method of delivery under the skin.*

FDA Label Image

Figure-11 (Figure 11)

An instructional illustration showing a person self-administering a Teriparatide injection subcutaneously in the abdomen. The image highlights the injection device held at a right angle to the skin, accompanied by a counting sequence from one to five, likely indicating a pause during or after injection.*

FDA Label Image

Figure-12 (Figure 12)

An instructional illustration showing a hand holding an injection pen with the thumb positioned on the black cap, indicating preparation or usage of the device, likely related to Teriparatide injection solution delivery.*

FDA Label Image

Figure-13 (Figure 13)

An instructional illustration showing a hand holding an injection pen with a finger positioned to press the top, overlaid by a red circle with a diagonal line indicating that pressing the top button is not allowed or should be avoided.*

FDA Label Image

Figure-14 (Figure 14)

An instructional illustration showing a hand holding a syringe labeled with a "Large needle cover." The image depicts the syringe tip being covered or uncovered by a needle cover, indicating safe handling or preparation for injection.*

FDA Label Image

Figure-15 (Figure 15)

An instructional illustration showing hands detaching a needle from a syringe by twisting it counterclockwise. The image guides proper removal technique for a subcutaneous injection device.*

FDA Label Image

Figure-16 (Figure 16)

An instructional illustration showing the steps to use a Teriparatide injection pen. It depicts a hand holding the pen with the cap on, followed by an arrow pointing to a hand removing the pen cap, indicating preparation for subcutaneous injection.*

FDA Label Image

Figure-17 (Figure 17)

An instructional illustration showing two hands holding parts of a pen or syringe device. One hand holds the main body with a visible dose window and plunger, while the other hand holds a cap being removed, indicated by a leftward-pointing arrow. The image depicts the process of removing the cap from a pen or syringe used for subcutaneous injection.*

FDA Label Image

Caption-2 (Figure 19)

An instructional illustration showing a hand holding a pen-like injection device with a red prohibition symbol overlay, indicating not to use the device in this manner or position.*

FDA Label Image

Figure-2 (Figure 2)

Illustration of Teriparatide injection delivery device parts. It labels components of the pen device including the red stripe, black injection button, yellow shaft, white body, label, medicine cartridge, white cap, paper tab, needle, small needle protector, and large needle cover. Note that needles are not included with the device.*

FDA Label Image

Figure-3 (Figure 3)

An instructional illustration showing hands preparing a Teriparatide 250 mcg/mL subcutaneous injection. One hand holds the syringe while the other removes the protective cap, indicated by an arrow pointing away from the syringe.*

FDA Label Image

Figure-4 (Figure 4)

An instructional illustration showing hands peeling off a paper tab from a circular object. The caption below reads 'Pull off paper tab.' This likely demonstrates a step in preparing the Teriparatide injection for use.*

FDA Label Image

Figure-5 (Figure 5)

An instructional illustration showing hands holding a prefilled injection syringe. One hand holds the syringe barrel while the other is removing a protective cap from the needle end. An arrow indicates the direction of cap removal, demonstrating preparation for subcutaneous injection.*

FDA Label Image

Figure-6 (Figure 6)

An instructional illustration showing hands removing a cap from a prefilled injection pen by twisting the cap downward, indicating preparation steps for subcutaneous injection.*

FDA Label Image

Figure-7 (Figure 7)

An instructional diagram showing a hand removing a large needle cover from a syringe. The image highlights the needle cover with a blue circle to emphasize the action of uncapping a large needle prior to injection.*

FDA Label Image

Figure-8 (Figure 8)

An instructional illustration depicting two hands holding a small vial or cartridge. One hand holds the vial vertically, while the other hand appears to be removing or attaching a small cap or cover from the vial's top. A downward arrow indicates the direction of the cap removal or attachment.*

FDA Label Image

Figure-9 (Figure 9)

An instructional illustration showing a hand removing a small needle protector from a syringe. The focus is on the needle tip and the small needle protector being pulled away, highlighting preparation for injection.*

FDA Label Image

Injection-label (Injection Label)

Label for Teriparatide Injection, USP 250 mcg/mL by Apotex Corp. The label states a dose of 20 mcg given once daily subcutaneously, with instructions for use of a single-patient-use prefilled pen delivering 28 subcutaneous doses. It advises refrigeration and not to freeze, and is marked Rx only.*

FDA Label Image

Structure (Structure)

Chemical structure diagram depicting the amino acid sequence of Teriparatide, labeled with amino acid abbreviations and position numbers along the polypeptide chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.